Your COVID-19 vaccine rollout questions, answered
OTTAWA -- Canada's vaccine rollout is now well into its second phase, with the continuous arrival of larger shipments of vaccines. There is a focus on seeing every eligible Canadian receive their first dose by the summer, and so shots are being administered to a growing number of eligible Canadians each day.
How is this all working?
CTVNews.ca spoke with experts on vaccine efficacy, public health and public opinion, logistics and ethics, and dove into testimony offered to federal policymakers to provide answers about where the mass vaccination effort stands, what’s ahead, and when it may be your turn to get the jab.
The federal government’s latest commitment is that between 48 and 50 million doses of approved vaccines will arrive in this country by Canada Day, doubling to more than 100 million doses by the end of September, more than enough shots to immunize the entire population.
For specifics on the size of coming deliveries, bookmark this.
First here are the basics:
- Canada currently has four COVID-19 vaccines approved for use: the Pfizer-BioNTech vaccine, the Moderna vaccine, the AstraZeneca vaccine and the Johnson & Johnson vaccine.
- As of early May, Canada has received shipments from all four approved vaccine developers, but the latest arrival, the Johnson & Johnson vaccine, is being held back by Health Canada so it can conduct some additional quality assurance checks after it was discovered it used a drug ingredient manufactured at a U.S. plant flagged for safety issues.
- The federal government has committed to having every eligible person—now anyone aged 12 and older—vaccinated who wants to be by the end of September 2021, with Prime Minister Justin Trudeau recently describing the path the country is on as one that will see a “one dose summer,” making way for a “two dose fall,” where life can start to return to normal.
- In total, Canada has contracts with seven vaccine manufacturers for doses of their shots. If all seven vaccine candidates are approved, those contracts would see this country have access to more than 400 million doses, which is way more than will be needed to immunize a population of approximately 38 million. This means the excess will likely be shared globally.
Now for the nitty-gritty:
(Reading this on an app? Click here for the interactive version)